BHV-1510 not checked

Biohaven · PBI-410 · GQ1010

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
1 active
1 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“BHV-1510 will be administered on Day 1 and Day 8 every 3 weeks”In the company’s words, NCT06384807 on ClinicalTrials.gov
Tested for
Solid Tumor
Main trialPhase 1/2
“This is a Phase 1/2, first in human (FIH), open-label, multicenter study of BHV-1510 monotherapy and in Combination with Cemiplimab in participants with previously treated, advanced solid tumors.”In the company’s words, NCT06384807 on ClinicalTrials.gov
Other names
PBI-410 · GQ1010

Other drugs for Solid Tumor

All 2440 drugs for Solid Tumor

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1/2Recruiting Feb 2028 A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow BHV-1510

Following is part of Solo: you see every change to BHV-1510 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in